Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said the deadline for determining efficacy is dependent on how quickly each trial enrolls people, administers the doses and then counts up who gets sick.
"I interacted with Olivia, I liked her, she was a good person, she was important to the team as a staff person to the Coronavirus task force. But I don't know what to make about what just has come out recently. It would be very difficult for me to comment on that," said Dr. Fauci.
© Copyright 2020 The Washington Times, LLC
3600 New York Avenue NE, Washington, DC 20002